Endurance Technologies IPO Opens Key Details and Market Outlook Vickers Top Insider Picks Signal Potential Confidence Amid Market Volatility Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers Trump Seeks Supreme Court Intervention to Halt TikTok Ban Michael Saylor Tokenization Could Create Free Market for Credit and Yield Challenging Traditional Banking SpaceX Delays Starships 12th Test Flight Eyes Friday Launch as V3 Version Debuts FSEA Q3 2024 Earnings Modest Profitability Achieved Amidst Challenging Environment MSN Q1 2024 Earnings Loss Reported as Stock Surges Over 20 VIPS Q4 2025 Earnings EPS Surprise Lifts Sentiment Amid Modest Stock Pullback NEOV Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction FENC Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amid Revenue Discontinuity TSS Inc TSSI Q1 2026 Earnings Stellar EPS Beat Drives Sharp Rally GitLab Inc GTLB Surges 433 as Developer Platform Stock Eyes Key Resistance Heartbeam Inc Warrant BEATW Rises 1077 as Tight Range Holds at 007 Interactive Strength Inc TRNR Plunges 15 Critical Support Tested After Steep Decline Sypris Solutions SYPR Edges Higher as Stock Tests Key Technical Levels Fulcrum Therapeutics FULC Steadies Near 657 as Biotech Sector Waits for Catalyst Michael Saylor of Strategy Says Tokenization Could Enable Investors to Shop for Yield Amdocs DOX Q1 2026 Earnings Slight EPS Miss Meets Modest Market Optimism AXIA Energia AXIA Retreats from Resistance Support Levels Under Scrutiny LQDA Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Amid Pipeline Updates MGEE Q1 2026 Earnings Earnings Beat Bolsters Utilitys Steady Profile Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Delivers Share Boost Amid Sparse Disclosures GSBC Q1 2026 Earnings EPS Surges 20 Above Estimates Amid Prudent Banking Operations Hillman Solutions HLMN Q1 2026 Earnings EPS Falls Short Amid Challenging Environment PLBC Q1 2026 Earnings EPS Beat of 712 Offsets Modest Share Price Decline MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline